At this time, patents prevent the manufacturing of a generic version of Alsuma. The first patent is scheduled to expire in August 2027, which would be the earliest date that a generic version could become available. However, lawsuits or other patents for new uses of the drug could change this date.
Can I Buy Generic Alsuma?Alsuma™ (sumatriptan) is a prescription medication that belongs to a group of drugs known as triptans. It is approved for treating migraines and cluster headaches. It is injected just under the skin (subcutaneously) using an autoinjector.
Alsuma is manufactured by Meridian Medical Technologies™, Inc. It is protected from generic competition by patents that have not yet expired.
When Will a Generic Version Be Available?The first patent is set to expire in August 2027. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific Alsuma uses. Once the drug goes off-patent, there may be several companies that manufacture a generic Alsuma drug.
Is Sumatriptan a Generic Alsuma?
No -- sumatriptan is the active ingredient of Alsuma (as well as in Sumavel®, Imitrex® products, and generic Imitrex products), not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
It is worth noting that none of the Sumavel, Imitrex, or generic Imitrex products are interchangeable with Alsuma. However, these products may be a more affordable option in some situations, depending on local pricing and insurance coverage.